Janssen Scientific Affairs, Llc

This program provides access to a specialized cell therapy called cilta-cel for patients with serious multiple myeloma when standard treatment options aren't available or feasible. The therapy involves modifying a patient's own immune cells to target cancer cells. This is for pat…

This study aims to compare the long-term safety of ustekinumab against other biologic drugs for adults with Crohn's disease or ulcerative colitis. Researchers will use existing military health records to track over 1,000 patients who are starting these treatments. The main goal i…